News - MedTech & Diagnostics
CEO roundtable to tackle private health deadlock
Australia’s largest medical indemnity provider representing 95,000 doctors, Avant Mutual, is stepping into the private healthcare policy battlefield, convening 36 […]
MoreNews - MedTech & Diagnostics
Cutting-edge technology meets outdated policy: MedTech Showcase lays bare health system paradox
At the Medical Technology Association of Australia (MTAA) MedTech on the Hill Showcase in Canberra, the power of innovation was […]
MoreNews - MedTech & Diagnostics
J&J MedTech debuts PFA technology in Australia to tackle atrial fibrillation
Johnson & Johnson MedTech has marked a new chapter in cardiac care with the first Australian clinical cases using the […]
MoreNews - MedTech & Diagnostics
World-first blood test heads to First Nations communities
A new blood test set to redefine how iron levels are measured is heading to the Northern Territory, as scientists […]
MoreNews - MedTech & Diagnostics
A southern hemisphere first: GE HealthCare partners with radiologists to redefine excellence in medical imaging
In this Health Industry Hub podcast that bridges clinical insights and technological ambition, Leon Berkovich, CEO of GE HealthCare, and […]
MoreNews - MedTech & Diagnostics
When insurers run the operating room: Medibank’s hospital power grab
Vertical integration in healthcare is linked to inefficiencies and higher costs for patients and taxpayers, according to a recent review. […]
MoreNews - MedTech & Diagnostics
NSW Premier shuts down calls for urgent inquiry into Western Sydney hospitals
The pressure on Western Sydney hospitals has reignited fierce political debate, with Premier Chris Minns rejecting calls for an inquiry […]
MoreNews - MedTech & Diagnostics
The cardiovascular blindspot exposed by a simple blood test
There is mounting evidence that elevated lipoprotein(a) [Lp(a)] is a strong, independent, and causal risk factor for cardiovascular disease. Yet, […]
MoreNews - MedTech & Diagnostics
National audit maps radiotherapy’s hits and misses in cancer care
The accuracy of stereotactic body radiotherapy (SBRT), a modern radiotherapy technique increasingly used for cancer care across Australia, has come […]
MoreNews - MedTech & Diagnostics
121 Policies, still no plan: Australia’s health workforce paradox
Australia’s health workforce is at breaking point. Wait times are growing, burnout is rising, and yet policy continues to proliferate, […]
MoreRecent Posts in Pharma, MedTech & Biotech
Senators fire sharp criticism at Labor Government inertia on HTA Review
September 2, 2025
in News - Pharmaceuticals
World-first DNA study puts prevention in focus, while government delay continues on promised legislation
September 2, 2025
in News - MedTech & Diagnostics
CEO roundtable to tackle private health deadlock
September 1, 2025
in News - MedTech & Diagnostics
Rare cancer patients pay the price of policy paralysis: New report
September 1, 2025
in News - Pharmaceuticals
PBS listing delivers first IL-4/IL-13 inhibitor for young children with severe asthma
September 1, 2025
in News - Pharmaceuticals
Pfizer’s pneumococcal vaccine funded after a blurry 1000+ days
September 1, 2025
in News - Pharmaceuticals
Second only to breast cancer: Women face rising blood cancer rates as funding lags decades behind
September 1, 2025
in News - Pharmaceuticals
Opposition and Independents turn up the heat on HTA Review delays
August 29, 2025
in News - Pharmaceuticals
Follow Us
Partner with us
News - Pharmaceuticals
Senators fire sharp criticism at Labor Government inertia on HTA Review
The chorus of frustration over delays in implementing the Health Technology Assessment (HTA) Review recommendations is growing louder. Senator Anne […]
MoreNews - MedTech & Diagnostics
World-first DNA study puts prevention in focus, while government delay continues on promised legislation
A world-first genetic study has revealed that one in 50 young Australians unknowingly carry genetic variants that put them at […]
MoreNews - MedTech & Diagnostics
CEO roundtable to tackle private health deadlock
Australia’s largest medical indemnity provider representing 95,000 doctors, Avant Mutual, is stepping into the private healthcare policy battlefield, convening 36 […]
MoreNews - Pharmaceuticals
Rare cancer patients pay the price of policy paralysis: New report
Rare Cancers Australia (RCA) is set to release a new report exposing the staggering disparities faced by Australians with rare […]
More